Country
Contract Development & Manufacturing Organizations in Denmark
Europe's peptide, insulin, and fermentation heartland. Compare EU-GMP Danish CDMOs across sterile fill-finish, biologics, and peptide manufacturing — by capability, certification, and site.
14 companies listed
Manufacturing sites in Denmark
The Danish CDMO landscape
Denmark is small by headcount and outsized by capability. Decades of insulin and enzyme production built a national specialisation in microbial and mammalian fermentation, peptide chemistry, and aseptic filling — precisely the capabilities the GLP-1 era has made scarce. Danish contract manufacturers inherited that industrial base, the engineering talent that came with it, and a supplier network for single-use consumables, media, and fill-finish equipment that few countries of comparable size can match.
Manufacturing is regulated by the Danish Medicines Agency (Lægemiddelstyrelsen), the national competent authority within the EU system. A GMP certificate issued in Denmark is recognised across the European Union, and marketing authorisation for most biologics runs through the EMA's centralised procedure rather than a country-by-country filing. The Danish Medicines Agency is an active participant in EU inspection work, which is one reason Danish sites turn up in FDA inspection records as often as they do for a country this size.
The trade-off is candid: Denmark prices with Northern Europe, not with Southern Europe or Asia, and its capacity is concentrated in a handful of very large sites rather than spread across a long tail of mid-size plants. Where it wins is on programmes whose difficulty lives in the process — peptides, sterile injectables, fermentation-derived biologics — and where a sponsor is willing to pay for a site that has run that exact unit operation at commercial scale for years.
Where Danish manufacturing actually happens
Kalundborg, on the west coast of Zealand, is the country's single most important pharmaceutical site — an integrated production campus for insulin and related biologics, and the anchor of a well-documented industrial symbiosis network where neighbouring plants trade steam, water, and process by-products. It is the reason Denmark has commercial-scale fermentation and API capacity out of proportion to its population.
Hillerød, north of Copenhagen, is the country's flagship contract-biologics location: a large-scale mammalian cell-culture site built by Biogen and acquired by FUJIFILM Diosynth Biotechnologies in 2019, since expanded and now one of the larger dedicated biologics CDMO campuses in Europe. For a sponsor evaluating Danish capacity, Hillerød is usually the first name on the list.
Greater Copenhagen sits inside Medicon Valley, the cross-border life-science cluster spanning eastern Denmark and southern Sweden over the Øresund link. That geography matters practically: a Danish CDMO engagement often has Swedish analytical, CRO, or secondary-packaging partners within driving distance, and the region shares a labour market for bioprocess engineers.
Companies (14)
AGC (AGC Biologics & AGC Pharma Chemicals)
Denmark
A
Axxam S.p.A.
Denmark
B
Bacthera
Denmark
BIOFAC A/S (BIOFAC Group)
Denmark
Caslo ApS
Denmark
F
FUJIFILM Biotechnologies / FUJIFILM Diosynth
Denmark
Gubra
Denmark
LGC Biosearch Technologies
Denmark
Metalogic
Denmark
NCK A/S (Niels Clauson-Kaas)
Denmark
NNE
Denmark
P
Phillips‑Medisize (a Molex company)
Denmark
Syntese
Denmark
Xellia Pharmaceuticals
Denmark
How this list is built: companies appear here when they have a manufacturing site in Denmark in our facilities dataset and pass the marketplace eligibility gate (pharmaceutical contract manufacturers only — CROs, equipment suppliers, and other non-manufacturers are excluded). Read the full methodology for the eligibility gates and how our ranked lists are computed.
Frequently Asked Questions
How many CDMOs are in Denmark?+
The live count and ranked list above are built from verified manufacturing sites in Denmark, not company headquarters — so the number reflects where production actually happens. Denmark's roster is deliberately smaller than Germany's or France's; its strength is depth in specific unit operations, not breadth.
What are Danish CDMOs strongest in?+
Peptide manufacturing, microbial and mammalian fermentation, sterile fill-finish, and large-scale biologics. The national insulin and enzyme heritage produced deep aseptic and fermentation expertise, which is now in heavy demand for GLP-1 and other peptide programmes.
Who regulates pharmaceutical manufacturing in Denmark?+
The Danish Medicines Agency (Lægemiddelstyrelsen) is the national competent authority. Danish sites operate under EU GMP, with certificates recognised across the EU, and most biologics reach the market through the EMA's centralised procedure. Many Danish sites also hold FDA registration for US-market supply — confirm the specific facility and product before contracting.
Is Denmark or Ireland the better EU biologics base?+
They solve different problems. Ireland offers breadth of biologics and API capacity, English-language operations, and decades of FDA-inspected export manufacturing. Denmark offers narrower but deeper capability in fermentation, peptides, and aseptic filling. For a GLP-1 or peptide programme, Denmark is frequently the stronger fit; for a broad biologics or small-molecule portfolio, Ireland usually is.
Find the right CDMO in Denmark
Our AI Matchmaker analyzes your project requirements and matches you with qualified Denmark manufacturing partners. Free for buyers.